Back to search
Hidradenitis Suppurativa (HS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hidradenitis Suppurativa (HS) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hidradenitis Suppurativa (HS) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The HS-RISE study aims to assess real-world HS treatment outcomes and patterns, safety of secukinumab, and to describe the baseline characteristics of patients…
The Global Healthcare Study on Hidradenitis Suppurativa (GHSHS) is an international, multicenter observational study hosted by the University of Zurich (UZH) in…
The purpose of the study is to assess the PK of bimekizumab following subcutaneous (sc) administration in study participants with moderate to severe hidradeniti…
This is a post-approval commitment study to evaluate efficacy, and safety of two dosing regimens of secukinumab (AIN457), 300 mg every four weeks (Q4W) and ever…
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and…
The primary purpose of the study is to evaluate the effect of brensocatib compared with placebo.
The medical and surgical treatment of hidradenitis suppurativa (HS) remains difficult to date. The search for new therapies for HS is a major challenge. The pat…